Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00247585 · ClinicalTrials.gov registry record · Phase 2
Hangover, Congeners, Sleep and Occupational Performance
A Phase 2 study of Sleep and Neurobehavioral Manifestations, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT00247585 is a Phase 2 study of Sleep and Neurobehavioral Manifestations that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 140 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00247585, a Phase 2 study of Sleep and Neurobehavioral Manifestations, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to investigate residual effects of heavy drinking, with or without hangover symptoms. The primary aim is to test several hypotheses about residual effects of heavy drinking. Hypotheses about how heavy drinking affects next-day performance include direct physiological effects of alcohol, alcohol withdrawal effects, and non-ethanol effects, such as congeners, or family history of alcohol problems. The investigators will test the following hypotheses: 1. relative to placebo, heavy drinking will degrade next-day performance, and this relationship will be mediated in full or in part by quality of sleep; 2. a high congener alcoholic beverage will affect performance to a greater degree than a low congener beverage and this relationship will be mediated by severity of hangover symptoms.
Conditions Studied
Interventions
- DRUG Ethanol (Bourbon or Vodka)
Study Locations (1)
Massachusetts
- General Clinical Research Center, Boston University School of Public Health/Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2003-09 |
| Est. Completion | 2006-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00247585
The ClinicalTrials.gov registry entry for NCT00247585 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower). The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sleep appearing as the primary indexed condition, and to 1 intervention - of which Ethanol (Bourbon or Vodka) is the first listed.
NCT00247585 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00247585 about?
NCT00247585 is a clinical study titled "Hangover, Congeners, Sleep and Occupational Performance". The objective is to investigate residual effects of heavy drinking, with or without hangover symptoms. The primary aim is to test several hypotheses about residual effects of heavy drinking. Hypotheses about how heavy drinking affects next-day performance include direct physiological effects of alco...
What is the current status of trial NCT00247585?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2003-09. Estimated completion is 2006-06.
What conditions does trial NCT00247585 study?
This clinical trial studies the following conditions: Sleep, Neurobehavioral Manifestations.
What interventions are being tested in trial NCT00247585?
The interventions under investigation include: Ethanol (Bourbon or Vodka) (DRUG).
Who is sponsoring clinical trial NCT00247585?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00247585 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING · Phase 2
-
Sleep Trial to Prevent Alzheimer's Disease
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.